Mereo BioPharma Group plc

MREO chart

Mereo BioPharma Group plc news

• BTIG Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $1

  Moomoo · Nov 10, 7:17 AM EST

• Mereo BioPharma Posts $800,000 in Q3 Revenue and $0.01 Loss Per Share

  TOKENPOST · Nov 10, 4:31 AM EST

• BTIG maintains Mereo BioPharma Group at Buy, keeps price target at $1

  TradingView · Nov 10, 3:27 AM EST

• Mereo BioPharma Group Releases Q3 2026 Financial Results

  AlphaStreet · Nov 9, 3:16 PM EST

• Mereo BioPharma Group plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

  marketscreener.com · Nov 9, 2:05 PM EST

• Mereo BioPharma (MREO) Advances Setrusumab and Alvelestat Programs, Eyes Pivotal 2027

  GuruFocus · Nov 9, 9:12 AM EST

• Form 8K MEREO BIOPHARMA GROUP PLC For: 9 November By Investing.com

  Investing.com India · Nov 9, 8:45 AM EST

• Mereo BioPharma 3Q 2026: Revenue $800K, EPS ($0.01) — 10-Q Summary

  TradingView · Nov 9, 8:41 AM EST

• Cash is expected to last into late 2027 as losses narrow at Mereo BioPharma (MREO).

  Stock Titan · Nov 9, 8:39 AM EST

• Mereo BioPharma reports Q3 EPS (1c), consensus (1c)

  TipRanks · Nov 9, 8:37 AM EST

• MEREO BIOPHARMA ($MREO) Releases Q3 2026 Earnings

  Quiver Quantitative · Nov 9, 8:35 AM EST

• Mereo BioPharma (MREO) Tops Q3 EPS by 1c

  StreetInsider · Nov 9, 8:32 AM EST

Mereo BioPharma Group plc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-09
• 8-K8-K2026-11-09
• 8-K8-K2026-08-19
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-05-14
• 8-K/A8-K/A2026-05-12
• 10-Q10-Q2026-05-12
• 8-K8-K2026-05-12
• DEF 14ADEF 14A2026-04-09
• 8-K8-K2026-03-27

About Mereo BioPharma Group plc

Ticker

MREO (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

London

Incorporated in

United Kingdom

Fiscal year end

December 31

SEC CIK

1719714

Frequently asked questions